🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 14 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/12/2013 | 45,68 | 46,69 | 45,47 | 46,66 | +2,09% | 2,67% | 14.200.086 |
| 17/12/2013 | 45,73 | 45,80 | 45,43 | 45,71 | -0,40% | 0,81% | 14.567.200 |
| 16/12/2013 | 46,09 | 46,36 | 45,70 | 45,89 | -0,60% | 1,45% | 11.893.962 |
| 13/12/2013 | 46,51 | 46,66 | 45,86 | 46,16 | +0,12% | 1,72% | 8.799.322 |
| 12/12/2013 | 46,35 | 46,55 | 45,83 | 46,11 | -1,29% | 1,54% | 12.169.062 |
| 11/12/2013 | 47,24 | 47,26 | 46,52 | 46,71 | -0,97% | 1,58% | 15.200.192 |
| 10/12/2013 | 47,02 | 47,28 | 46,85 | 47,17 | -0,26% | 0,91% | 10.727.747 |
| 09/12/2013 | 47,12 | 47,57 | 46,95 | 47,29 | +0,34% | 1,32% | 9.779.412 |
| 06/12/2013 | 46,88 | 47,30 | 46,72 | 47,13 | +1,19% | 1,24% | 7.758.554 |
| 05/12/2013 | 46,67 | 46,99 | 46,54 | 46,57 | -1,01% | 0,98% | 9.140.551 |
| 04/12/2013 | 47,33 | 47,38 | 46,58 | 47,05 | -0,90% | 1,67% | 12.001.277 |
| 03/12/2013 | 47,54 | 47,77 | 47,12 | 47,48 | -0,84% | 1,37% | 14.257.411 |
| 02/12/2013 | 47,46 | 48,11 | 47,46 | 47,88 | +0,70% | 1,37% | 15.541.735 |
| 29/11/2013 | 47,51 | 47,66 | 47,21 | 47,55 | +0,00% | 0,94% | 7.231.200 |
| 27/11/2013 | 47,32 | 47,62 | 47,29 | 47,55 | +0,50% | 0,71% | 12.120.644 |
| 26/11/2013 | 47,39 | 47,47 | 46,91 | 47,31 | -0,16% | 1,19% | 24.040.386 |
| 25/11/2013 | 46,71 | 47,56 | 46,70 | 47,39 | +1,47% | 1,84% | 19.159.641 |
| 22/11/2013 | 46,27 | 46,79 | 46,22 | 46,70 | +0,66% | 1,24% | 14.638.359 |
| 21/11/2013 | 46,01 | 46,47 | 45,95 | 46,39 | +1,02% | 1,12% | 13.453.281 |
| 20/11/2013 | 45,78 | 46,20 | 45,56 | 45,93 | +0,12% | 1,40% | 8.647.991 |
| 19/11/2013 | 45,85 | 45,96 | 45,47 | 45,87 | +0,12% | 1,08% | 8.745.874 |
| 18/11/2013 | 45,84 | 46,05 | 45,59 | 45,81 | -0,12% | 1,00% | 8.310.745 |
| 15/11/2013 | 45,45 | 46,07 | 45,45 | 45,87 | +0,52% | 1,36% | 12.567.092 |
| 14/11/2013 | 45,34 | 45,68 | 45,32 | 45,63 | +1,01% | 0,78% | 11.822.069 |
| 13/11/2013 | 44,60 | 45,20 | 44,51 | 45,17 | -0,53% | 1,54% | 14.836.955 |
| 12/11/2013 | 44,80 | 45,45 | 44,66 | 45,41 | +1,26% | 1,77% | 14.620.229 |
| 11/11/2013 | 44,76 | 44,99 | 44,73 | 44,85 | +0,43% | 0,58% | 7.895.003 |
| 08/11/2013 | 43,83 | 44,72 | 43,76 | 44,66 | +2,14% | 2,20% | 18.260.142 |
| 07/11/2013 | 44,04 | 44,12 | 43,68 | 43,72 | -0,30% | 1,00% | 12.235.819 |
| 06/11/2013 | 43,47 | 43,91 | 43,26 | 43,86 | +1,32% | 1,49% | 12.954.642 |